Haemodynamic and Respiratory Effects of Dexmedetomidine as an Adjuvant to Oxycodone Patient-Controlled Analgesia After Lumbar Spinal Fusion: A Post Hoc Analysis of the DoseRespDex Randomised Controlled Trial.
Sanna Mäkelä, Teijo I Saari, Eliisa Löyttyniemi et al.
✦ AI-curated · Sources linked
In 30 seconds
This post hoc analysis of a randomised, double-blind, placebo-controlled trial examined haemodynamic and respiratory effects of dexmedetomidine added to oxycodone patient-controlled analgesia in 98 adults undergoing lumbar spinal fusion. Participants received oxycodone alone or with one of three dexmedetomidine concentrations for 24 hours. Over 72 hours, mean arterial pressure was lower with 5 μg/mL and 10 μg/mL dexmedetomidine than with oxycodone alone; all dexmedetomidine doses reduced heart rate. These changes resolved by 48 hours. No bradycardia occurred, and measured respiratory variables did not differ between groups.
Key findings
- Over 72 h, MAP was lower in D5 versus D0 (-11.2 mmHg, 95% confidence interval [CI] -19.9 to -2.5, p = 0.004) and D10 versus D0 (-9.1 mmHg, 95% CI -17.4 to -0.8, p = 0.032).
- Heart rate was lower versus D0 with D2 (-10.2 bpm), D5 (-9.9 bpm) and D10 (-11.9 bpm); all p < 0.01, with no differences among dexmedetomidine doses.
- Haemodynamic changes resolved by 48 h; no bradycardia occurred, and measured respiratory variables did not differ between groups.
- Median peak plasma dexmedetomidine concentrations were 0.15, 0.31 and 0.55 ng/mL in D2, D5 and D10, respectively.
Why it matters
Dexmedetomidine added to opioid PCA may affect blood pressure and heart rate even when measured respiratory outcomes show no between-group differences. The transient haemodynamic changes and absence of observed bradycardia provide useful safety information for this postoperative setting, while the lack of a clear dose-response pattern cautions against assuming that higher concentrations produce proportionally greater haemodynamic effects.
What to keep in mind
This was a post hoc analysis of a trial, and the findings apply to the studied lumbar spinal fusion population, PCA regimen and 72-hour observation period.